Resources>Citations Database>PlexinD1 is a driver and a therapeutic target in advanced prostate cancer

PlexinD1 is a driver and a therapeutic target in advanced prostate cancer

Biointron 2025-01-02

Authors: Jing Wei, Jing Wang, Wen Guan, Jingjing Li, Tianjie Pu, Eva Corey, Tzu-Ping Lin, Allen C Gao, and Boyang Jason Wu

Journal: EMBO Mol Med

PubMed ID: 39748059

DOI: https://doi.org/10.1038/s44321-024-00186-z

Products & Services: The D1SP sequence was generated by fusing a signal peptide sequence, human PlexinD1 Sema domain (aa 49–547) and PSI domain (aa 548–601), a G4S linker, and a hinge sequence to human IgG1 followed by codon optimization and synthesized by Biointron Biological


Subscribe to our Citations Database
Recommended Articles
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma
Nov 25, 2025
Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybri……

Aug 07, 2025
Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025
Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.